Related Experiment Videos
Cybernetics, activation, and drug effects.
1New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, New York.
Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1988
Summary
Psychopharmacology can simplify complex patient conditions by targeting core pathophysiology. This study proposes a cybernetic model for affective-activation control systems, linking it to pleasure regulation and various psychiatric disorders.
Area of Science:
- Psychiatry
- Neuroscience
- Computational Biology
Background:
- Patient presentations involve complex interactions of familial, developmental, social, affective, cognitive, and symptomatic factors.
- Psychopharmacological treatments offer a method to address this complexity by targeting underlying pathophysiology.
- Certain psychiatric disorders, including depressions, manic states, panic disorder, emotionally unstable character disorders, and schizophrenias, can achieve remission with medication.
Purpose of the Study:
- To propose a cybernetic model for understanding the pathophysiology of affective-activation control systems.
- To explore the relationship between defects in these control systems, pleasure regulation mechanisms, and psychiatric disorders.
- To provide a framework for understanding the benefits of psychopharmacological interventions.
Main Methods:
- Conceptual analysis and theoretical modeling.
- Review of existing literature on psychopharmacology and psychiatric disorders.
- Application of cybernetic principles to psychiatric pathophysiology.
Main Results:
- Affective-activation control system derangement is proposed as a core mechanism in treatable psychiatric disorders.
- Defects in this system are best understood through a cybernetic lens, moving beyond traditional rheostat models.
- Disorders of appetitive and consummatory pleasure regulation mechanisms are linked to affective states and drug abuse.
Conclusions:
- A cybernetic conceptualization of affective-activation control system defects provides a framework for understanding psychopathology and psychopharmacological benefits.
- This model highlights a close relationship between bipolar affective disorders and schizophrenias.
- The proposed schema integrates understanding of hedonic control mechanisms, affective states, and substance abuse.